Dragon and Tiger List | Lionco (603669) hits the daily limit, reason for listing: the closing price increase deviation of the top five securities with a price fluctuation limit reaches 7%同壁财经·Jun 8 at 05:30 AM603669+6.94%02611-0.99%
YesAsia Holdings And 2 Other Promising Penny Stocks In GlobalSimplywall·Jun 8 at 04:24 AM603669+6.94%
Lionco: Subsidiary Lionco Pharmaceutical's product, injectable cefazolin sodium, is expected to be selected for national centralized drug procurementZhitong·Oct 29, 2025 at 02:58 AM603669+6.94%
The A-share CRO concept sector has seen a surge, with Lionco hitting the daily limit, MeHow rising over 10%, and Haoyuan Pharmaceutical, Boji Pharmaceutical, Medicilon, Sun-Novo, and Heyuan Biotechnology also following suitZhitong·Aug 24, 2025 at 09:14 PM688202+2.36%688621+0.70%
The chemical pharmaceutical sector continues to rise, with SUNHERE and Lionco hitting the daily limitZhitong·Jun 30, 2025 at 08:51 PM603669+6.94%300452+0.91%
CRO concept stocks partially rose, Lionco surged to the daily limitZhitong·Jun 29, 2025 at 08:50 PM301096+5.17%688602+0.95%
Lionco: Wholly-owned subsidiary receives clinical trial approval notice for acetazolamide sustained-release capsule medicationZhitong·Apr 28, 2025 at 03:06 AM603669+6.94%
Lionco released its first-quarter performance, with a net loss attributable to the parent company of 18.62 million yuanZhitong·Apr 25, 2025 at 05:20 AM603669+6.94%
The chemical pharmaceutical sector fluctuated and strengthened, with HC CHEMICAL and Lionco hitting the limit-upZhitong·Apr 23, 2025 at 08:42 PM603669+6.94%300267+2.73%
Lionco released its 2024 annual performance, with a net loss attributable to the parent company of 131 million yuanZhitong·Apr 18, 2025 at 07:15 AM603669+6.94%
Lionco: Injectable Vecuronium Bromide has passed the consistency evaluation for generic drugsZhitong·Apr 11, 2025 at 02:38 AM603669+6.94%
Lionco's wholly-owned subsidiary has obtained the registration certificate for Naloxone Hydrochloride InjectionZhitong·Mar 11, 2025 at 03:29 AM603669+6.94%
Lionco announced a pre-loss, expecting a net loss of 120 million yuan for the fiscal year 2024Zhitong·Jan 16, 2025 at 02:52 AM603669+6.94%
Lionco: Expected net loss of approximately 120 million yuan in 2024Zhitong·Jan 16, 2025 at 02:40 AM603669+6.94%
